HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Evans, D G Articles by Narod, S A Search for Related Content PubMed PubMed Citation Articles by Evans, D G Articles by Narod, S A Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Genetics Home Reference

Is CHEK2 a cause of the Li–Fraumeni syndrome?

¹ Academic Unit of Medical Genetics and Regional Genetics Service, St Mary’s Hospital, Manchester, UK
² CR-UK Paediatric and Familial Cancer Research Group, Royal Manchester Children’s Hospital, Manchester, UK
³ Centre for Research in Women’s Health, Women’s College Hospital, Toronto, Ontario, Canada

Correspondence to:
Professor D G Evans, Academic Unit of Medical Genetics & Regional Genetics Service, St Mary’s Hospital, Hathersage Road, Manchester, M13 0JH, UK; gareth.evans@cmmc.nhs.uk]

The first 150 words of the full text of this article appear below.

We have reviewed the evidence for CHEK2 as a cause of Li–Fraumeni syndrome (LFS) in view of the continued debate about the cancer spectrum associated with mutations in this gene.¹ In 1969 Li and Fraumeni reported four families with an autosomal dominant predisposition to a range of cancer types in children and young adults, including soft tissue sarcoma and breast cancer.² In 1988, they extended their analysis to 24 families to characterise better the phenotype of the syndrome.³ These families contained greater than expected numbers of soft tissue sarcomas, osteosarcomas, breast cancers, childhood adrenocortical carcinomas, brain tumours and leukaemia. This group of cancers was soon accepted as the formal criteria for the clinical definition of classical LFS (box 1).

Box 1 Li–Fraumeni syndrome (LFS) criteria Proband with any bone or soft tissue sarcoma, diagnosed under the age of 45 years one first degree relative with cancer under 45 years of age and one first or . . . [Full text of this article]